Search Results

You are looking at 91 - 100 of 124 items for :

  • "papillary" x
  • Refine by Access: All x
Clear All
Full access

Jeffrey F. Moley

Hauptmann S Dralle H . Prediction of lateral lymph node metastases in medullary thyroid cancer . Br J Surg 2008 ; 95 : 586 – 591 . 24. Solorzano CC Evans DB . Same-day ultrasound guidance in reoperations for locally recurrent papillary

Full access

Robert J. Morgan Jr, Ronald D. Alvarez, Deborah K. Armstrong, Robert A. Burger, Lee-may Chen, Larry Copeland, Marta Ann Crispens, David M. Gershenson, Heidi J. Gray, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A. Matulonis, David M. O’Malley, Richard T. Penson, Matthew A. Powell, Steven W. Remmenga, Paul Sabbatini, Joseph T. Santoso, Julian C. Schink, Nelson Teng, Theresa L. Werner, Mary A. Dwyer, and Miranda Hughes

, although MMMT has not been included in IP chemotherapy trials. 21 , 38 However, MMMT/carcinosarcoma is basically papillary serous carcinoma (ie, a poorly differentiated carcinoma); therefore, IP may be used for MMMT. NCCN Guidelines Insights

Full access

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020

Featured Updates to the NCCN Guidelines

Robert J. Motzer, Eric Jonasch, M. Dror Michaelson, Lakshminarayanan Nandagopal, John L. Gore, Saby George, Ajjai Alva, Naomi Haas, Michael R. Harrison, Elizabeth R. Plimack, Jeffrey Sosman, Neeraj Agarwal, Sam Bhayani, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Thomas H. Gallagher, Steven L. Hancock, Christos Kyriakopoulos, Chad LaGrange, Elaine T. Lam, Clayton Lau, Bryan Lewis, Brandon Manley, Brittany McCreery, Andrew McDonald, Amir Mortazavi, Phillip M. Pierorazio, Lee Ponsky, Bruce G. Redman, Bradley Somer, Geoffrey Wile, Mary A. Dwyer, CGC, Lydia J. Hammond, and Griselda Zuccarino-Catania

, multicenter study . J Clin Oncol 2009 ; 27 : 5794 – 5799 . 19826129 10.1200/JCO.2008.21.4809 17. Ficarra V , Schips L , Guillè F , . Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized

Full access

Philippe E. Spiess, Simon Horenblas, Lance C. Pagliaro, Matthew C. Biagioli, Juanita Crook, Peter E. Clark, Richard E. Greenberg, and Cesar E. Ercole

staging system in 2010, and recognizes 4 subtypes of SCC: verrucous, papillary squamous, warty, and basaloid (“see Staging Table, in the NCCN Clinical Practice Guidelines in Oncology for Penile Cancer, available online at NCCN.org [ST-1]”). Adenosquamous

Full access

Mary B. Daly, Robert Pilarski, Jennifer E. Axilbund, Michael Berry, Saundra S. Buys, Beth Crawford, Meagan Farmer, Susan Friedman, Judy E. Garber, Seema Khan, Catherine Klein, Wendy Kohlmann, Allison Kurian, Jennifer K. Litton, Lisa Madlensky, P. Kelly Marcom, Sofia D. Merajver, Kenneth Offit, Tuya Pal, Huma Rana, Gwen Reiser, Mark E. Robson, Kristen Mahoney Shannon, Elizabeth Swisher, Nicoleta C. Voian, Jeffrey N. Weitzel, Alison Whelan, Myra J. Wick, Georgia L. Wiesner, Mary Dwyer, Rashmi Kumar, and Susan Darlow

tumours in Norway: a nested case-control study . Br J Cancer 2004 ; 91 : 1829 – 1834 . 12. Jazaeri AA Lu K Schmandt R . Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma . Mol Carcinog 2003 ; 36 : 53

Full access

John P. Sherbeck, Lili Zhao, and Richard W. Lieberman

. Int J Gynecol Cancer 2015 ; 25 : 1437 – 1444 . 5. Alagkiozidis I Weedon J Grossman A . Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: a

Full access

Robert J. Morgan Jr, Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Kian Behbakht, Lee-may Chen, Larry Copeland, Marta Ann Crispens, Maria DeRosa, Oliver Dorigo, David M. Gershenson, Heidi J. Gray, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A. Matulonis, David M. O'Malley, Richard T. Penson, Sanja Percac-Lima, Mario Pineda, Steven C. Plaxe, Matthew A. Powell, Elena Ratner, Steven W. Remmenga, Peter G. Rose, Paul Sabbatini, Joseph T. Santoso, Theresa L. Werner, Jennifer Burns, and Miranda Hughes

endometrioid carcinomas, clear cell carcinomas, and papillary serous carcinomas. 9 – 11 In women at high risk (with either BRCA1 or BRCA2 mutations), prophylactic bilateral salpingooophorectomy (BSO) is associated with a reduced risk for breast, ovarian

Full access

Amy Ly, Jill C. Ono, Kevin S. Hughes, Martha B. Pitman, and Ronald Balassanian

, radial scar in an excision specimen, and papilloma. Indeterminate lesions encompassed radial scar in a core biopsy, atypical papillary lesion, flat epithelial atypia (FEA), atypical ductal hyperplasia, atypical lobular hyperplasia/lobular carcinoma in

Full access

Kari E. Hacker, Shitanshu Uppal, and Carolyn Johnston

common, more frequently bilateral (30%–40%), confined to the ovaries, and likely to exhibit benign behavior even at higher stages. 39 , 40 Updated genetic assessments suggest that seromucinous BOTs do not have a serous component despite some papillary

Full access

Stephanie A. Terezakis and Nancy Y. Lee

Wells SA . Compartment-mediated dissection for papillary thyroid cancer . Langenbecks Arch Surg 1999 ; 384 : 9 – 15 . 5. Azrif M Slevin NJ Sykes AJ . Patterns of relapse following radiotherapy for